Ultragenyx Stock In The News
RARE Stock | USD 41.62 0.82 2.01% |
Our overall analysis of Ultragenyx's news coverage and content from conventional and social sources shows investors' bearish mood towards Ultragenyx. The specific impact of Ultragenyx news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ultragenyx's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ultragenyx headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ultragenyx Backtesting and Ultragenyx Hype Analysis. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.
Ultragenyx |
Ultragenyx Today Top News and Investor Outlook
Ultragenyx Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ultragenyx and other traded companies coverage with news coverage. We help investors stay connected with Ultragenyx headlines for the 26th of February to make an informed investment decision based on correlating the impacts of news items on Ultragenyx Stock performance. Please note that trading solely based on the Ultragenyx hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ultragenyx stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ultragenyx earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ultragenyx that are available to investors today. That information is available publicly through Ultragenyx media outlets and privately through word of mouth or via Ultragenyx internal channels. However, regardless of the origin, that massive amount of Ultragenyx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ultragenyx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ultragenyx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ultragenyx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ultragenyx alpha.
Ultragenyx Largest EPS Surprises
Earnings surprises can significantly impact Ultragenyx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2015-05-11 | 2015-03-31 | -0.54 | -0.63 | -0.09 | 16 | ||
2020-10-27 | 2020-09-30 | -1.26 | -1.13 | 0.13 | 10 | ||
2015-11-09 | 2015-09-30 | -0.87 | -1.03 | -0.16 | 18 | ||
2024-08-01 | 2024-06-30 | -1.69 | -1.52 | 0.17 | 10 | ||
2019-08-01 | 2019-06-30 | -1.7 | -1.89 | -0.19 | 11 | ||
2015-08-13 | 2015-06-30 | -0.63 | -0.83 | -0.2 | 31 |
Ultragenyx Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ultragenyx Stock. Current markets are strongly bullish. About 86% of major world exchanges and indexes are currently up. See today's market update for more information.
25th of February 2025
Ultragenyx Pharmaceutical Inc Announces Participation in Upcoming Investor Conferences at gurufocus.com

19th of February 2025
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635 at globenewswire.com

18th of February 2025
Ultragenyx Announces FDA Acceptance and Priority Review of the Biologics License Applicati... at gurufocus.com

14th of February 2025
Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase YY at finance.yahoo.com

13th of February 2025
Ultragenyx Q4 Earnings Taking a Look at Key Metrics Versus Estimates at finance.yahoo.com

10th of February 2025
Wellington Management Group LLP Reduces Stake in Ultragenyx Pharmaceutical Inc at gurufocus.com

22nd of January 2025
Rhythm Pharmaceuticals Soars 5.5 percent Is Further Upside Left in the Stock at zacks.com

6th of January 2025
European Commission Extends the Approval of Evkeeza to Children as Young as 6-months Old w... at finance.yahoo.com

13th of December 2024
Y Intercept Hong Kong Ltd Buys 12,617 Shares of Ultragenyx Pharmaceutical Inc. at thelincolnianonline.com
Ultragenyx Investors Sentiment
The influence of Ultragenyx's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ultragenyx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ultragenyx's public news can be used to forecast risks associated with an investment in Ultragenyx. The trend in average sentiment can be used to explain how an investor holding Ultragenyx can time the market purely based on public headlines and social activities around Ultragenyx. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ultragenyx's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ultragenyx's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ultragenyx's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ultragenyx.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ultragenyx in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ultragenyx's short interest history, or implied volatility extrapolated from Ultragenyx options trading.
Check out Ultragenyx Backtesting and Ultragenyx Hype Analysis. For information on how to trade Ultragenyx Stock refer to our How to Trade Ultragenyx Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ultragenyx. If investors know Ultragenyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ultragenyx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.29) | Revenue Per Share | Quarterly Revenue Growth 0.294 | Return On Assets | Return On Equity |
The market value of Ultragenyx is measured differently than its book value, which is the value of Ultragenyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ultragenyx's value that differs from its market value or its book value, called intrinsic value, which is Ultragenyx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ultragenyx's market value can be influenced by many factors that don't directly affect Ultragenyx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ultragenyx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ultragenyx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ultragenyx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.